Antimicrobial

Diseases for which medicine is efficacious
- Acute exacerbation of chronic respiratory disease (chronic bronchitis)
- Community-acquired pneumonia
- Rhinosinusitis
- Otitis media

Fluoroquinolone-based drugs, including this drug, are related to serious adverse events, so acute bacterial sinusitis and acute bacterial exacerbations of chronic bronchitis are used in patients without other treatment options.

FACTIVE® Tab. can be taken with or without food and should be swallowed whole with a liberal amount of liquid. The recommended dose of FACTIVE® Tab. is 320 mg daily, according to the following.
* Recommended Dosage Regimen of FACTIVE® Tab.
The clinical decision regarding the use of a 5 day or 7 day regimen should be guided by results of the initial sputum culture.
The recommended dose and duration of FACTIVE® Tab. should not be exceeded.
- Use in Renally Impaired Patients:
Dose adjustment in patients with creatinine clearance >40 mL/min is not required. Modification of the dosage is recommended for patients with creatinine clearance ≤40 mL/min.
- Use in Hepatically Impaired Patients:
No dosage adjustment is recommended in patients with mild (Child-Pugh Class A), moderate (Child-Pugh Class B) or severe (Child-Pugh Class C) hepatic impairment.
- Use in Elderly:
No dosage adjustment is recommended.